All doses of Eli Lilly's Zepbound and Mounjaro are now available, the FRA's updated shortage list shows. However, the regulator has not yet removed the drugs off its shortage list.
Eli Lilly and Danish rival Novo Nordisk are racing to increase production in a weight-loss drug market estimated to reach about $150 billion by early 2030s.
Four drugmakers involved in the first U.S. negotiations over prices for Medicare say they do not expect a significant impact on their businesses after seeing confidential suggested prices from the government for their drugs that will take effect in 2026.
Semaglutide, the active ingredient in drugs like Wegovy and Ozempic, can help people lose weight — and a new study says it may also help people quit smoking.